PT  - JOURNAL ARTICLE
AU  - Williams, Lynn
AU  - Gallant, Allyson J.
AU  - Rasmussen, Susan
AU  - Brown Nicholls, Louise A.
AU  - Cogan, Nicola
AU  - Deakin, Karen
AU  - Young, David
AU  - Flowers, Paul
TI  - Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content
AID  - 10.1101/2020.06.16.20132480
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.16.20132480
4099  - http://medrxiv.org/content/early/2020/06/17/2020.06.16.20132480.short
4100  - http://medrxiv.org/content/early/2020/06/17/2020.06.16.20132480.full
AB  - Objectives Development of a vaccine against COVID-19 will be key to controlling the pandemic. We need to understand the barriers and facilitators to receiving a future COVID-19 vaccine so that we can provide recommendations for the design of interventions aimed at maximising vaccine uptake by the public.Design Cross-sectional survey with ‘high-risk’ individuals (older adults aged 65+ and patients with chronic respiratory disease).Methods During the UK’s early April 2020 ‘lockdown’ period, participants (N=527; mean age = 59.5 years) completed an online questionnaire assessing willingness to receive a COVID-19 vaccine, perceptions of COVID-19, and intention to receive other vaccinations. The questionnaire included a free text response (n=502) to examine barriers and facilitators to uptake. The Behaviour Change Wheel informed the analysis of these responses, which were coded to the Theoretical Domains Framework (TDF). Behaviour change techniques (BCTs) were identified.Results Eighty-six percent of respondents want to receive a COVID-19 vaccine. This was positively correlated with the perception that COVID-19 will continue for a long time, and negatively associated with the perception that the media has over-exaggerated the risk. The majority of barriers and facilitators could be mapped onto the ‘beliefs about consequences’ TDF domain, with themes relating to personal health, health consequences to others, concerns of vaccine safety, and severity of COVID-19.Conclusions Willingness to receive a COVID-19 vaccination is currently high among high-risk individuals. Mass media interventions aimed at maximising vaccine uptake should utilise the BCTs of information about health, emotional, social and environmental consequences, and salience of consequences.What is already known on this subject?Uptake of a vaccine for COVID-19 will be vital for controlling the pandemic, but the success of this strategy relies on public acceptance of the vaccine.Uptake of vaccinations and public confidence in vaccines has been falling in recent years.Evidence suggests that 26% of the French population would not want to receive a COVID-19 vaccination.What does this study add?This study found that 86% of our sample of high-risk participants in the UK are willing to receive a future vaccine for COVID-19.This study showed that perceived barriers and facilitators to uptake of the COVID-19 vaccination concentrated on the ‘beliefs about consequences’ TDF domain.This study suggests that the content of mass media interventions to improve vaccine uptake should focus on the BCTs of information about health, emotional, social and environmental consequences, and salience of consequences. These techniques should be pitched in relation to both self and, most importantly, to others.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of StrathclydeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are not publicly available due to privacy or ethical restrictions.